Tuesday, December 23, 2025
Home Authors Posts by Ogkologos

Ogkologos

4103 POSTS 0 COMMENTS

FDA Approves Pembrolizumab with Chemotherapy for Primary Advanced or Recurrent Endometrial...

Ogkologos -
0

A Favourable Benefit-Risk Profile for Taletrectinib in TKI-Naїve and Crizotinib-Pretreated Patients...

Ogkologos -
0

After 5 Years of Follow-Up, the Median PFS Has Yet To...

Ogkologos -
0

Adding Olanzapine to Standard Triple Antiemetic Therapy for the Prevention of...

Ogkologos -
0

Development of T-Cell Lymphoma After Chimeric Antigen Receptor T-Cell Therapy

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Odronextamab

Ogkologos -
0

Entrectinib Is Effective and Well Tolerated in Patients with Treatment-Naïve ROS1-positive...

Ogkologos -
0

FDA Approves Durvalumab with Chemotherapy for Mismatch Repair Deficient Primary Advanced...

Ogkologos -
0

Treating the Whole Person: How Cancer Centers Are Addressing Social Needs

Ogkologos -
0

One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among...

Ogkologos -
0
1...464748...411Page 47 of 411

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com